VRCI vs. YGEN, GENI, ABDX, AGL, PRM, IDHC, GDR, DMTR, LLAI, and LLA
Should you be buying Verici Dx stock or one of its competitors? The main competitors of Verici Dx include Yourgene Health (YGEN), GENinCode (GENI), Abingdon Health (ABDX), ANGLE (AGL), Proteome Sciences (PRM), Integrated Diagnostics (IDHC), genedrive (GDR), Deepmatter Group (DMTR), LungLife AI (LLAI), and LLA.L,0P0001T9GN,0 (LLA). These companies are all part of the "diagnostics & research" industry.
Verici Dx vs. Its Competitors
Yourgene Health (LON:YGEN) and Verici Dx (LON:VRCI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.
23.3% of Yourgene Health shares are owned by institutional investors. Comparatively, 15.6% of Verici Dx shares are owned by institutional investors. 64.4% of Yourgene Health shares are owned by company insiders. Comparatively, 1.0% of Verici Dx shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Verici Dx has lower revenue, but higher earnings than Yourgene Health. Verici Dx is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.
In the previous week, Verici Dx had 2 more articles in the media than Yourgene Health. MarketBeat recorded 2 mentions for Verici Dx and 0 mentions for Yourgene Health. Yourgene Health's average media sentiment score of 0.00 beat Verici Dx's score of -1.22 indicating that Yourgene Health is being referred to more favorably in the media.
Yourgene Health has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Comparatively, Verici Dx has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500.
Yourgene Health has a net margin of -27.55% compared to Verici Dx's net margin of -110.99%. Yourgene Health's return on equity of -27.06% beat Verici Dx's return on equity.
Summary
Yourgene Health beats Verici Dx on 8 of the 12 factors compared between the two stocks.
Get Verici Dx News Delivered to You Automatically
Sign up to receive the latest news and ratings for VRCI and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Verici Dx Competitors List
Related Companies and Tools
This page (LON:VRCI) was last updated on 10/6/2025 by MarketBeat.com Staff
